HomeLIXT • NASDAQ
Lixte Biotechnology Holdings Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 774.81K | -23.22% |
Net income | -775.67K | 23.27% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 887.21K | -65.81% |
Total assets | 1.19M | -55.44% |
Total liabilities | 537.12K | 27.44% |
Total equity | 651.46K | — |
Shares outstanding | 4.56M | — |
Price to book | 22.63 | — |
Return on assets | -143.33% | — |
Return on capital | -213.97% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -775.67K | 23.27% |
Cash from operations | -487.49K | 40.48% |
Cash from investing | — | — |
Cash from financing | -10.00K | — |
Net change in cash | -497.49K | 39.26% |
Free cash flow | -8.37K | 98.10% |
Previous close
$5.43
Day range
$5.27 - $5.68
Year range
$0.64 - $6.26
Market cap
24.13M USD
Avg Volume
159.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2005
Website
Employees
2
